Clinical Thiazolidinediones as PPAR&ggr; Ligands with the Potential for the Prevention of Cardiovascular Disease in Diabetes

By  

Current Diabetes Reviews, Vol. 2, Iss. 2, 2006-05 ,pp. : 227-239

Bentham Science Publishers

Access to resources Recommend Favorite

Thiazolidinediones: Beyond Glycemic Control

By Reynolds Kathryn   Goldberg Ronald B.  

Treatments in Endocrinology, Vol. 5, Iss. 1, 2006-01 ,pp. : 25-36

Adis International

Access to resources Recommend Favorite

Is Ramadan Fasting Safe in Type 2 Diabetic Patients in View of the Lack of Significant Effect of Fasting on Clinical and Biochemical Parameters, Blood Pressure, and Glycemic Control?

By M'guil M.   Ragala M. A.   El Guessabi L.   Fellat S.   Chraibi A.   Chebraoui L.   Israili Z. H.   Lyoussi B.  

Clinical and Experimental Hypertension, Vol. 30, Iss. 5, 2008-07 ,pp. : 339-357

Informa Healthcare

Access to resources Recommend Favorite

Role of Prostaglandin (PG) and Peroxisome Proliferator-Activated Gamma (PPAR &ggr; ) in Pulmonary Fibrosis

By  

Current Respiratory Medicine Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 3-5

Bentham Science Publishers

Access to resources Recommend Favorite

Angiotensin Receptor Blockers and Target-Organ Protection Beyond Blood Pressure Control

By Riccardo Sarzani   Paolo Dessì-Fulgheri   Alessandro Rappelli  

High Blood Pressure & Cardiovascular Prevention, Vol. 11, Iss. 2, 2004-01 ,pp. : 65-73

Adis International

Access to resources Recommend Favorite